Related Experiment Videos
Dendritic cells prevent radiation-induced thymic lymphoma
E F Potworowski1, F Gagnon, C Beauchemin
1Centre de Recherche en Immunologie, Institut Armand-Frappier, Laval-des Rapides, QC, Canada.
Leukemia
|October 1, 1996
Summary
Bone marrow prevents lymphoma in mice by supplying thymic dendritic cells. These cells are crucial for abrogation, unlike thymocytes, highlighting their role in lymphoma prevention.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- X-irradiation induces thymic lymphomas in C57BL/Ka mice.
- Bone marrow transplantation abrogates lymphoma development.
- The mechanism of abrogation by bone marrow is not fully understood.
Purpose of the Study:
- To investigate the role of thymic dendritic cells and thymocytes in preventing radiation-induced thymic lymphomas.
- To elucidate the cellular components of bone marrow responsible for lymphoma abrogation.
Main Methods:
- C57BL/Ka mice were subjected to split-dose X-irradiation.
- Mice received injections of syngeneic bone marrow, early thymocytes, or immortalized thymic dendritic cells.
- Lymphoma incidence was monitored over 36 weeks.
- Pre-lymphoma cell potential was assessed in thymuses of survivors.
Main Results:
- Both bone marrow and dendritic cell injections significantly reduced lymphoma incidence.
- Thymocyte injections did not prevent lymphoma development.
- Dendritic cell-treated mice showed an intermediate level of lymphomagenic potential in their thymuses compared to bone marrow-treated and untreated mice.
Conclusions:
- Marrow-derived thymic dendritic cells play a key role in abrogating radiation-induced thymic lymphomas.
- The protective effect of bone marrow involves the contribution of dendritic cells to the thymus.
- This study identifies thymic dendritic cells as critical mediators in preventing lymphoma development.